🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

2 Tablet(s) Serving Size
30 Servings
Botanical Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 400.0mg (380 products) 📚 34 studies (Tier A: 1, B: 10)
This product: 450mg
Goldenseal
380 mg
📊 Market median: 500.0mg (115 products)
Median 500.0mg This product: 250mg
Proprietary Blend (Herb/Botanical)
190 mg

Other Ingredients

Sorbitol Stearic Acid Silica modified Cellulose Gum Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (74% of products) Nutrient (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: 2 tablets twice daily between meals.

⚠️ Warnings & Precautions

Warning: Do not use if you are pregnant, may become pregnant, or breastfeeding.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

🧪 Formulation Notes

Echinacea-Goldenseal with Olive Leaf

This combination is further enhanced by the addition of European olive leaf plus other key Western and Chinese botanicals such as garlic, isatis, and andrographis.

Additional Information

Supports immune system 635 mg

Formulated by Michael Tierra L.Ac, O.M.D

Echinacea and goldenseal are the two most relied-upon botanicals for winter health. Echinacea reigns supreme as North America’s primary immune-enhancing botanical.

PF0446 REV K151-C

Product Details

UPC / SKU 0 21078 10446 9
DSLD Entry Date 2017-11-20
Product Type Botanical
Form Tablet or Pill
DSLD ID 80287
Data Updated 2026-04-11

Research Evidence

38 Research Sources
52 Avg Quality Score
15 Meta Analysis
12 Systematic Review
6 Rct
2 Clinical Trial
1 Regulatory Source
1 Openfda Safety
A Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2014
B Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis
Meta Analysis Clinical nutrition ESPEN 2025
B Echinacea for preventing and treating the common cold
Systematic Review The Cochrane database of systematic reviews 2000
B Echinacea Supplementation Does Not Impact Aerobic Capacity and Erythropoiesis in Athletes: A Meta-Analysis
Meta Analysis Nutrients 2024
B Echinacea for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2006
B Therapeutic Potential of a Natural Blend of Aronia melancarpa, Lonicera caerulea, and Echinacea purpurea Extracts in Treating Upper Respiratory Tract Infections: Preliminary Clinical and In Vitro Immunomodulatory Insights
Rct International journal of molecular sciences 2024
B Herbal Medicine in Children With Respiratory Tract Infection: Systematic Review and Meta-Analysis
Meta Analysis Academic pediatrics 2018
B Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Meta Analysis The Lancet. Infectious diseases 2007
B Herbal Medicine for Cough: a Systematic Review and Meta-Analysis
Meta Analysis Forschende Komplementarmedizin (2006) 2015
B Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysis
Meta Analysis Complementary therapies in medicine 2019
View all evidence for Echinacea →

Compare Similar Products

View all Echinacea products →